Tomi Rantamäki - Concepedia

Author

Tomi Rantamäki

Also Known As

Rantamäki, Tomi, T RANTAMAKI, T Rantamäki, T. Rantamaki, T. Rantamäki, Tomi P. J. Rantamäki, Tomi Rantamaki, Tomi Rantamki, Tomi RantamÃ¤ki, Tomi Rantamäki

113

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Roche (Switzerland)University of Eastern Finland Karolinska Institutet Institute for Molecular Medicine Finland

About

Tomi Rantamäki is an author at University of Helsinki specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1.6K
2	Social Sciences	13	13	1.1K
3	Health Sciences	1	1	17
4	Natural Sciences	1	1	190
5	Public Health	1	1	29

Tomi Rantamäki

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain Tomi Rantamäki, Panu Hendolin, Aino Kankaanpää, Neuropsychopharmacology Molecular PharmacologyPsychiatryMedicineSynaptic TransmissionPsychotropic Medication	2007	302
Biosynthesis and Intracellular Targeting of the CLN3 Protein Defective in Batten Disease Irma Järvelä, Markku Sainio, Tomi Rantamäki, Human Molecular Genetics Cln3 Protein DefectiveBatten DiseaseIntracellular TargetingHela Cell LinesLysosomal Compartment	1998	190
Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade Tomi Rantamäki, Liisa Vesa, Hanna Antila, PLoS ONE	2011	123
Enhanced BDNF Signaling is Associated with an Antidepressant-like Behavioral Response and Changes in Brain Monoamines Eija Koponen, Tomi Rantamäki, Vootele Võikar, Cellular and Molecular Neurobiology NeuropsychologyPsychopathologyPsychoactive DrugPsychiatryBehavioral Neuroscience	2005	122
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice Jesse Lindholm, Henri Autio, Liisa Vesa, Neuropharmacology Molecular PharmacologyPsychiatryNeurophysiologyAntidepressant-like EffectsMedicine	2011	102
BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse Verna Louhivuori, Annalisa Vicario, Marko Uutela, Neurobiology of Disease Knockout MouseDevelopmental BiologyMolecular NeuroscienceNeuroanatomyFmr1-knockout Mouse	2010	98
Cholesterol Loss Enhances TrkB Signaling in Hippocampal Neurons Aging in Vitro M. Martín, Simona Perga, Laura Trovò, Molecular Biology of the Cell	2008	93
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice Susanna Kemppainen, Tomi Rantamäki, André Jerónimo-Santos, Neurobiology of Aging App/ps1 MiceSignal TransductionMemory LossReceptor Tyrosine KinaseMemory	2011	90
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits Gorka Gereñu, Eva Martišová, Hilda Ferrero, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Bdnf CleavageAlzheimer's DiseaseMedicineDementiaNeuropharmacology	2017	86
Isoflurane produces antidepressant effects and induces TrkB signaling in rodents Hanna Antila, Maria Ryazantseva, Dina Popova, Scientific Reports	2017	86

Page 1